Emerging preclinical evidence supports a potential role for cannabidiol in the management of sickle cell disease

Arne M. De Kreuk, Matthew A. Howard, Kate Gardner, Olivia S. Kowalczyk

Open source

DOI
10.3324/haematol.2026.300736
Published
2026-05-28
Container
Haematologica
Publisher
Ferrata Storti Foundation (Haematologica)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2026.300736,
  title = {Emerging preclinical evidence supports a potential role for cannabidiol in the management of sickle cell disease},
  author = {Arne M. De Kreuk and Matthew A. Howard and Kate Gardner and Olivia S. Kowalczyk},
  year = {2026},
  journal = {Haematologica},
  doi = {10.3324/haematol.2026.300736},
  url = {https://doi.org/10.3324/haematol.2026.300736}
}

RIS

TY  - JOUR
TI  - Emerging preclinical evidence supports a potential role for cannabidiol in the management of sickle cell disease
AU  - Arne M. De Kreuk
AU  - Matthew A. Howard
AU  - Kate Gardner
AU  - Olivia S. Kowalczyk
PY  - 2026
JO  - Haematologica
DO  - 10.3324/haematol.2026.300736
UR  - https://doi.org/10.3324/haematol.2026.300736
ER  - 

APA

Kreuk, A. M. D., Howard, M. A., Gardner, K., & Kowalczyk, O. S. (2026). Emerging preclinical evidence supports a potential role for cannabidiol in the management of sickle cell disease. Haematologica. https://doi.org/10.3324/haematol.2026.300736

Source records